Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field
Cipla stock trades at ₹1,388, down 0.48% or ₹6.70 from its previous close of ₹1,394.70
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Cipla (CIPLA).
- Category: Stocks.
Why it matters
A routine update for Cipla. Use the price and stock snapshot to gauge how the market is responding.







